Pembrolizumab induced pneumonitis

Last revised by Daniel J Bell on 6 Oct 2021

Pembrolizumab induced pneumonitis is a form of drug-induced lung disease occurring as a result of a response to the use of the programmed cell death protein 1 (PD1) inhibitor pembrolizumab. It may have variable pattern 2

Pembrolizumab is also reported to have a high risk of inducing lung injury in patients with pre-existing interstitial lung disease 3.

See also

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.